'Oncology Market Forecast to 2013' available now through Aarkstore Enterprise
10/27/2009

"Oncology Market Forecast to 2013," explores the fiercely competitive oncology market in a way that no other available forecast can match.

Online PR News – 27-October-2009 – – Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of additional public and private databases worldwide.

Give your brand team all the oncology data it needs to make critical product decisions!

Key Questions This Report Will Answer:
* Which drugs will make the most money in the next five years?
* Which drug classes are poised for exponential growth?
* Whose portfolio will allow them to jump out in front of the oncology market?
Table of Contents :

Chapter 1: Analysis of Cancer Drugs by Classes (130+ Drug Profiles)
- BRAND INFORMATION
Brand and generic name
Drug class
Delivery mechanism
Line of treatment
- SALES DATA
Historical/current sales
Forecasted sales
- APPROVED INDICATIONS
- CURRENT PRODUCT DEVELOPMENT PHASES
- COMPETITIVE AND STRATEGIC POSITIONING
- MARKET OPPORTUNITIES AND BRAND GROWTH
- PATENT, GENERIC AND LITIGATION INFORMATION
Chapter 2: Oncology Indications
- ANALYSIS OF MARKETS FOR DIFFERENT CANCER TYPES
Current sales, major drugs and important companies
Forecasted sales and assessment of future drugs and market players
Pipeline development status
Major market events, changes in treatments, patent expirations, etc.
Chapter 3: Top Companies’ Oncology Portfolios
- ANALYSIS OF MAJOR ONCOLOGY COMPANIES
Current sales, major drugs and important companies
Forecasted sales and assessment of future drugs and market players
Pipeline development status

For more information, please visit :
http://www.aarkstore.com/reports/Oncology-Market-Forecast-to-2013-6776.html
Or email us at press@aarkstore.com or call +919272852585

visit our website